• Empagliflozin’s Impact: Long-Term Cardiorenal Protection for CKD Patients

  • 2025/02/02
  • 再生時間： 16 分
  • ポッドキャスト

Empagliflozin’s Impact: Long-Term Cardiorenal Protection for CKD Patients

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this episode, we explore the groundbreaking results of the EMPA-KIDNEY trial, a large-scale clinical study that highlights the long-term benefits of Empagliflozin (SGLT2 inhibitor) in patients with chronic kidney disease (CKD). We dive into how the treatment slowed disease progression, reduced cardiovascular deaths, and provided lasting benefits even after the therapy ended. Join us as we break down the study’s key findings, discuss their real-world implications, and uncover what makes this treatment a game-changer for CKD management.

    🔗 Full Study Details: NEJM - EMPA-KIDNEY Study
    🔗 ClinicalTrials.gov: EMPA-KIDNEY NCT03594110


    Links to the Podcast

    • Apple Podcast: ⁠Listen on Apple Podcast⁠
    • Spotify: ⁠Listen on Spotify⁠
    • Amazon Music: ⁠Listen on Amazon Music⁠
    • YouTube: ⁠Watch on YouTube⁠


    #Podcast #Empagliflozin #ChronicKidneyDisease #CKDManagement #EMPA_KIDNEY_Study #SGLT2Inhibitors #RenalHealth #CardioRenalProtection #ClinicalResearch #MedicalBreakthroughs #LongTermBenefits
    続きを読む 一部表示

あらすじ・解説

In this episode, we explore the groundbreaking results of the EMPA-KIDNEY trial, a large-scale clinical study that highlights the long-term benefits of Empagliflozin (SGLT2 inhibitor) in patients with chronic kidney disease (CKD). We dive into how the treatment slowed disease progression, reduced cardiovascular deaths, and provided lasting benefits even after the therapy ended. Join us as we break down the study’s key findings, discuss their real-world implications, and uncover what makes this treatment a game-changer for CKD management.

🔗 Full Study Details: NEJM - EMPA-KIDNEY Study
🔗 ClinicalTrials.gov: EMPA-KIDNEY NCT03594110


Links to the Podcast

  • Apple Podcast: ⁠Listen on Apple Podcast⁠
  • Spotify: ⁠Listen on Spotify⁠
  • Amazon Music: ⁠Listen on Amazon Music⁠
  • YouTube: ⁠Watch on YouTube⁠


#Podcast #Empagliflozin #ChronicKidneyDisease #CKDManagement #EMPA_KIDNEY_Study #SGLT2Inhibitors #RenalHealth #CardioRenalProtection #ClinicalResearch #MedicalBreakthroughs #LongTermBenefits
続きを読む 一部表示
activate_buybox_copy_target_t1

Empagliflozin’s Impact: Long-Term Cardiorenal Protection for CKD Patientsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。